Amir Fathi
Associate Professor of Medicine at Harvard Medical School
Schools
- Harvard Medical School
Links
Biography
Harvard Medical School
Dr. Amir Fathi graduated summa cum laude from Yale University with a BS degree in molecular, cellular, and developmental biology. He went on to receive his medical degree with honors at the Yale School of Medicine. He also has a master’s degree in epidemiology from Harvard School of Public Health. Dr. Fathi completed his residency training in internal medicine at Massachusetts General Hospital (MGH), and fellowships in both hematology and medical oncology at Johns Hopkins Hospital. He is the Program Director of the Center for Leukemia at the Massachusetts General Hospital Cancer Center; he is also an Associate Professor in Medicine at Harvard Medical School.
Dr. Fathi has presented at national meetings of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH), spoken at national academic and educational meetings, and has served on national committees that establish guidelines for the management of acute and chronic leukemias. As faculty at the MGH Cancer Center and Harvard Medical School, Dr. Fathi provides clinical care, supervises trainees, administers a busy clinic, and as the director of clinical research in leukemia, is the lead investigator on numerous clinical trials investigating novel treatments in acute leukemias. His other interests focus on developing translational projects to discover new targets for therapy.
Outcomes for patients with acute myeloid leukemia (AML) continue to be poor despite incremental advances in treatment and supportive care over the last 30 years. Although most patients respond to initial treatment, the majority eventually relapse and many succumb to their disease. Therefore, new and innovative approaches are desperately needed to significantly improve outcomes. As a clinician-scientist with a deep interest in developing novel therapies for AML, Dr. Fathi endeavors to provide outstanding clinical care, teaching, and mentoring, while also conducting translational projects, retrospective research, and clinical trials, with the overarching goal improving the health and outcomes of patients with bone marrow malignancies.
Departments, Centers, & Programs:
- Cancer Center
- Leukemia
- Hematology/Oncology
Clinical Interests:
- Acute Lymphocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic myelogenous leukemia
- Myelodysplastic syndrome (MDS)
- Myeloproliferative diseases
Medical Education
- MD, Yale University School of Medicine
- Residency, Massachusetts General Hospital
- Fellowship, Johns Hopkins Hospital
American Board Certifications
- Hematology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Videos
Updates on IDH inhibition in AML
Immuno-oncology: what is next for AML?
Results of trial of vadastuximab talirine plus hypomethylating agents in AML
Ixazomib plus chemotherapy for AML & ALL
How could new immunotherapy modalities in AML change current practice?
Differentiation syndrome with lower-intensity therapy for AML
Assist. Prof. Amir Fathi | ASH 2017 | Updates in IDH inhibitors in AML
Novel FLT3 inhibitors for AML
Aurora A kinase inhibitor alisertib and chemo is promising for untreated high-risk AML
Amir Fathi | Alisertib in combination with induction chemotherapy in high-risk patients with AML
Venetoclax in AML: Safety Profile
How could new immunotherapy treatments in AML change current practice?
SGN-CD33A Plus Hypomethylating in frontline Unfit AML patients
IDH1/2 inhibitors for upfront AML therapy and transfusion independence
AML post-transplant maintenance: enasidenib & ivosidenib
Updates on KO-539 as a treatment for AML
Read about executive education
Other experts
Popular Courses
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Jun 23
Leading People and Teams
ESMT
Berlin, Germany
May 28
Leading Digital Transformation
ESMT
Berlin, Germany
May 28
Leading Strategic Growth and Change
Columbia Business School
New York, New York, United States
Jun 10
The Manchester Leadership Development Programme
Alliance Manchester Business School
Manchester, United Kingdom
Jul 1
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Sep 8
Looking for an expert?
Contact us and we'll find the best option for you.